HONG KONG, Aug. 25, 2022 /PRNewswire/ — CNOOC Limited (the “Company”, SEHK: 00883, SSE: 600938) today announced its 2022 interim results for the six months ended June 30, 2022. During the period, the Company focused on the main business sector of hydrocarbon exploration and development….
Related Posts
Battery Energy Storage Systems Global Market Report 2022: Robust Outlook for EVs Opens New Avenues of Growth for EV Batteries & BESS Integrated EVCS Market
DUBLIN, Aug. 15, 2022 /PRNewswire/ — The “Battery Energy Storage Systems – Global Market Trajectory & Analytics” report has been…
Ceramic Sanitary Ware Market to Exceed US$ 58,929.8 Mn by 2032 Owing to its Excellent Chemical and Scratch Resistance Properties | Future Market Insights, Inc.
South Asia is expected to be the most remunerative market in the ceramic sanitary ware market, followed by North America.…
Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.
Pharma Desk, India: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from the US Food & Drug Administration (USFDA) for its Abbreviated New Drug Application (ANDA) for Ivabradine Tablets, 5 mg and 7.5 mg. The tentatively approved ANDA is therapeutically equivalent to the reference listed drug product (RLD) Corlanor Tablets, 5…
Read More “Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg.” »
The post Alembic Pharmaceuticals receives USFDA Tentative Approval for Ivabradine Tablets, 5 mg and 7.5 mg. appeared first on NEWSX 360 : The Global News Platform.